SCHEMBL2905281

SCHEMBL2905281

O=C(O)N1CCN(Cc2cn(-c3ccccc3)nc2-c2ccco2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.62
KDM4E B2RXH2 5/20 0.62
MAPT P10636 3/20 0.62
NPC1 O15118 1/20 0.62
NPSR1 Q6W5P4 4/20 0.48
USP2 O75604 3/20 0.48
POLB P06746 3/20 0.48
PKM P14618 2/20 0.48
HTT P42858 2/20 0.48
ALOX15 P16050 2/20 0.48
TSHR P16473 2/20 0.48
HSD17B10 Q99714 2/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
ALOX12 P18054 1/20 0.47
PLA2G7 Q13093 1/20 0.46
MGLL Q99685 1/20 0.46
ABHD6 Q9BV23 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
DRD2 P14416 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2905976 0.89 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2902226 0.87 SSTR5 (0.49) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2908047 0.86 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2910372 0.85 ALDH1A1 (0.49) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2907039 0.84 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2902823 0.84 ALDH1A1 (0.64) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2909630 0.83 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2907786 0.80 ALDH1A1 (0.61) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL2907045 0.78 ALDH1A1 (0.39) ALDH1A1KDM4EMAPTNPC1NPSR1
SCHEMBL21802547 0.78 DRD2 (0.72) ALDH1A1KDM4EMAPTNPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611107-B1 1,3,4-SUBSTITUTED PYRAZOLES FOR USE AS 5-HT RECEPTOR ANTAGONISTS IN THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS MERCK PATENT GMBH (DE) 2010-08-18 EP claimed